Journal Guide

Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal will focus on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterise the relationship between in vitro and in vivo findings. The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals). Toxicology in Vitro discourages papers that record reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.NEW! Special rate for ESTIV members now available. For more information contact Dr. Maria Laura ScarinoNational Research Institute on Food and Nutrition (INRAN)Via Ardeatina 54600178 Rome, ItalyTel: +39 06 51494497Fax: +39 06 51 494550E-mail: scarino@inran.itor visit the ESTIV website at http://www.estiv.org/Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Toxicon's "aims and scope" are laid down in the journal as:To publish:articles containing the results of original research on problems related to toxins derived from animals, plants and microorganismspapers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxinsmolecular biological studies of toxin and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxinsclinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtainedmaterial on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problemsreview articles on problems related to toxinology.AndTo encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the International Society on Toxinology.Toxicon strives to publish articles that are current and of broad interest and importance to the toxinology research community. Emphasis will be placed upon articles that further the understanding and knowledge of toxinology.Types of paperFull-Length Research Papers: Articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms.Short Communications: Short communications differ from full manuscripts only in that the research study does not lend itself to an extended presentation. Even though brief, the Short communication should represent a complete, coherent and self contained study. The quality of Short Communications is expected to be as good as that of full articles, and both full articles and Short communications will be refereed in an identical manner. The form is identical to that for a full article except that the report should not be divided into Introduction, Materials and Methods, Results and Discussion. An abstract of not more than 75 words should be provided. The Short Communication may not be longer than five double-spaced typewritten pages (not including references, tables and figures) and should include not more than two tables of two figures or one of each.Letters to the Editor: These may be published if judged by the Editor to be of interest to the broad field of toxinology or of special significance to a smaller group of workers in a specialized field of toxinology. They should be headed `Letter to the Editor' which should be followed by a title for the communication. Names of authors and affiliations should be at the end of the letter.Announcements: Toxicon will only accept for publication announcements of great interest to toxinologists, such as notices of appropriate meetings and symposia and activities of the International Society of Toxinology.Reviews and mini-Reviews: Articles of interest to toxinologists which are published in journals other than Toxicon may be abstracted in the Reviews section of Toxicon. Readers who feel that a particular article or book should be abstracted in this section are encouraged to bring their opinions to the attention of one of the Review Editors. Mini-Reviews and proposals for mini-Reviews are welcomeMolecular Biology: Papers on molecular biological aspects of toxins are welcome. They can include cloning, expression, genetic and related studies. The papers must add to the understanding of the role or function of toxins. Papers providing cDNA sequences without any relevant conclusions are not acceptable. If cDNA sequences are included, authors must guarantee that the sequences will be deposited in a public gene bank before the publication of the paper in Toxicon.Clinical reports: Toxicon will publish clinical reports on poisoning where a new therapeutic principle has been proposed or a decidedly superior clinical result has been established. Please observe the following: Clinical Reports GuidelinesClassic Toxins: The main aim of these articles is to educate and inform both the experienced scientist and new scientists entering the field of toxinology. These articles should serve as a reference guide for anyone using toxins. Please contact Dr. Ed Rowan with your suggestions for inclusion in the 'classic toxins' feature.

The Transactions of Nonferrous Metals Society of China, founded in 1991 and sponsored by The Nonferrous Metals Society of China, is published bimonthly and mainly contains reports of original research which reflect progress in the field of nonferrous metals science and technology, including mineral processing, extraction metallurgy, metallic materials and heat treatments, metal working, physical metallurgy, powder metallurgy, with the emphasis being on materials science and engineering.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Transfusion Clinique et Biologique publishes original papers, general reviews, clinical cases, letters to the editor and editorials concerning transfusion activity in all its scientific and medical aspects.
Articles in English are also accepted.
In the CME section, update articles are published, together with self-evaluations and litterature reviews.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/623385/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Transfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues. Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators' viewpoint. Another section is "What's Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/709553/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Topics published in Translational Research in Anatomy include anatomy in all of its aspects, especially those that have application to other scientific disciplines including the health sciences:
• gross anatomy
• neuroanatomy
• histology
• immunohistochemistry
• comparative anatomy
• embryology
• molecular biology
• microscopic anatomy
• forensics
• imaging/radiology
• medical education

Priority will be given to studies that clearly articulate their relevance to the broader aspects of anatomy and how they can impact patient care. Strengthening the ties between morphological research and medicine will foster collaboration between anatomists and physicians. Therefore, Translational Research in Anatomy will serve as a platform for communication and understanding between the disciplines of anatomy and medicine and will aid in the dissemination of anatomical research.

The journal accepts the following article types:
1. Review articles
2. Original research papers
3. New state-of-the-art methods of research in the field of anatomy including imaging, dissection methods, medical devices and quantitation
4. Education papers (teaching technologies/methods in medical education in anatomy)
5. Commentaries
6. Letters to the Editor
7. Selected conference papers

All papers should be submitted in English and must be original work that is unpublished and not under consideration by another journal. An international Editorial Board and reviewers from the anatomical disciplines guarantee a rapid review of your paper within two to three weeks after submission.

Keywords:
Anatomy, neuroanatomy, developmental, biology, surgery, medicine, health care, histology, embryology, translational research, morphology, imaging, radiology, science, integration, molecular biology, basic science, forensics, MRI, 3D imaging

Since 2009, Transnational Corporations Review (TNCR) has served as one of the few outlets in international business and economics that encourages and publishes cooperative efforts among academics, policymakers and industry practitioners. Published quarterly, TNCR is an international journal that places a particular emphasis on the presence and interactions of emerging markets within the global economy, while providing a unique balance of both macro and micro issues.

The journal’s topics range broadly and include:

• globalization;
• internationalization of firms;
• transnational corporations' management;
• corporate social responsibility;
• offshoring;
• global value chains;
• foreign direct investments;
• institutional innovations;
• policies and governance;
• international trade and development.

Peer Review Policy
All submitted manuscripts are subject to initial appraisal by the managing editor(s) and then peer-review by independent, anonymous expert referees if the managing editors found suitable for further consideration. All peer review is single-blind and submission is via email to tncr.special@gmail.com.

STAR
Taylor & Francis/Routledge are committed to the widest possible dissemination of its journals to non-profit institutions in developing countries. Our STAR initiative offers individual researchers in Africa, South Asia and many parts of South East Asia the opportunity to gain one month’s free online access to 1,300 Taylor & Francis journals. For more information, please visit the STAR website.

Please bookmark this URL: http://www.elsevier.com/locate/trim

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/620925/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Aims and Scope:
Transplantation Proceedings publishes several different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication.

The first type of manuscripts consists of sets of papers providing an in-depth expression of the current state of the art in various rapidly developing components of world transplantation biology and medicine. These manuscripts emanate from congresses of the affiliated transplantation societies, from Symposia sponsored by the Societies, as well as special Conferences and Workshops covering related topics.

Transplantation Proceedings also publishes several special sections including publication of Clinical Transplantation Proceedings, being rapid original contributions of preclinical and clinical experiences. These manuscripts undergo review by members of the http://www.journals.elsevier.com/transplantation-proceedings/editorial-board/Editorial Board.